Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis

Patients with Crohn's disease who are candidates for infliximab therapy should be tested for hepatitis B serological markers before treatment and considered for prophylaxis of reactivation using antiviral therapy if positive.